AMBROSI, BRUNO EUGENIO
 Distribuzione geografica
Continente #
EU - Europa 4.553
NA - Nord America 2.808
AS - Asia 1.480
SA - Sud America 76
OC - Oceania 9
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.935
Nazione #
US - Stati Uniti d'America 2.680
GB - Regno Unito 1.900
CN - Cina 775
IT - Italia 625
DE - Germania 529
SE - Svezia 520
UA - Ucraina 263
TR - Turchia 189
KR - Corea 156
IN - India 144
FR - Francia 135
EU - Europa 126
CA - Canada 120
RU - Federazione Russa 118
IE - Irlanda 117
FI - Finlandia 116
NL - Olanda 100
HK - Hong Kong 83
CO - Colombia 61
VN - Vietnam 56
GR - Grecia 54
SG - Singapore 33
BE - Belgio 23
PL - Polonia 23
ID - Indonesia 19
DK - Danimarca 13
JP - Giappone 11
AU - Australia 7
BR - Brasile 7
UZ - Uzbekistan 5
MX - Messico 4
AT - Austria 3
CH - Svizzera 3
CR - Costa Rica 3
AL - Albania 2
AR - Argentina 2
CL - Cile 2
EG - Egitto 2
ES - Italia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TH - Thailandia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
MD - Moldavia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
SO - Somalia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 9.058
Città #
Southend 1.771
Chandler 439
Seattle 255
Jacksonville 217
Beijing 214
Milan 198
Princeton 190
Ann Arbor 143
Redmond 118
Wilmington 117
Dublin 116
Mountain View 104
Nanjing 94
Toronto 85
Dearborn 81
Ashburn 80
Sakarya 77
Woodbridge 76
Hong Kong 70
Somerville 64
Andover 63
Serra 63
Bogotá 61
Des Moines 58
Boardman 54
Hanover 54
Athens 53
Bengaluru 49
Houston 41
Frankfurt am Main 40
Pisa 40
Fuzhou 37
Lowell 36
Jinan 35
Helsinki 33
Berlin 31
Phoenix 31
Shenyang 31
New York 30
Eitensheim 26
Fairfield 26
Grafing 25
Ottawa 25
Dong Ket 24
Nanchang 24
Brussels 23
Redwood City 23
Shanghai 23
Tianjin 22
Cornate D'adda 21
Warsaw 21
Hebei 19
Kunming 19
Hamburg 16
Zhengzhou 16
Auburn Hills 15
Mumbai 14
Rochester 14
Changsha 13
Haikou 12
Kwai Chung 12
Chaoyang 11
Hangzhou 11
Ningbo 11
Verona 11
Cambridge 10
Guangzhou 10
Pune 10
Putian 10
Turin 10
Kiez 9
Los Angeles 9
Nürnberg 9
Bitonto 8
Rome 8
San Diego 8
Taizhou 8
Roxbury 7
Vittuone 7
Bologna 6
Hefei 6
Odernheim 6
Piscataway 6
Seoul 6
Bühl 5
Jiaxing 5
Bornova 4
Florence 4
Medford 4
Montreal 4
Naples 4
Stiens 4
Taiyuan 4
Bangalore 3
Brugherio 3
Cupertino 3
Hammonton 3
Heredia 3
Lanzhou 3
Lucca 3
Totale 6.038
Nome #
Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures 289
Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency 220
Sindrome di Cushing : forme atipiche 168
Soluble adhesion molecules levels in patients with Cushing's syndrome before and after cure 167
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus : effect of glycemic control and visceral adiposity on Leydig cell function 167
Prevalence of GH deficiency in cured acromegalic patients : impact of different previous treatments 160
Gonadal failure is associated with visceral adiposity in myotonic dystrophies 154
Cortisol secretion in patients with type 2 diabetes : relationship with chronic complications 148
GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency 148
Post-surgical hypocortisolism after removal of an adrenal incidentaloma : is it predictable by an accurate endocrinological work-up before surgery? 144
Effect of recombinant hGH (rhGH) replacement on gonadal function in male patients with organic adult-onset GH deficiency 143
Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism : an Italian multicenter study 143
The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma 142
Echocardiographic alterations in patients with non-functioning adrenal incidentaloma 141
Malattia di Cushing resistente alle terapie convenzionali : ruolo della surrenectomia bilaterale per via laparoscopica 140
Association of subclinical hypercortisolism with type 2 diabetes mellitus : a case-control study in hospitalized patients 138
Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentalomA 138
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients 137
Assessing the presence of abnormal regulation of cortisol secretion by membrane hormone receptors : in vivo and in vitro studies in patients with functioning and non-functioning adrenal adenoma 136
Thyroid acropachy: An unusual rheumatic manifestation of Graves' disease 134
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 133
Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma 129
Association of increased plasma cardiotrophin-1 with left ventricular mass indexes in normotensive morbid obesity 128
Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency : a metaanalysis 128
Thyroid function and body weight : should we also consider the interplay with insulin resistance and fat distribution? 128
Effects of chronic administration of PPAR-γ ligand rosiglitazone in Cushing's disease 127
Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing's disease 124
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas 123
Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism 121
Malattie del sistema endocrino diffuso, poliendocrinopatie, sindromi paraneoplastiche 121
Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly 121
Ipertensione endocrina 120
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy 120
Relationship of thyroid function with body mass index and insulin-resistance in euthyroid obese subjects 119
Androgen and cortisol secreting adrenocortical adenoma may also be "subclinical" 118
Epicardial fat thickness : relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity 117
Increased risk for non-autoimmune hypothyroidism in young patients with congenital heart defects 116
Adjuvant mitotane therapy for adreno-cortical carcinoma 115
L'utilità dell'oral glucose tolerance test nella diagnosi di diabete mellito 115
Subclinical hypercortisolism : correlation between biochemical diagnostic criteria and clinical aspects 114
Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism 112
Modifications in serum growth hormone concentration induced by sulpiride in acromegalic patients pretreated with dopamine, bromocriptine, and metergoline 112
Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin 109
Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause 109
Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration 108
Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies 108
Iperocortisolsimo subclinico e diabete mellito tipo 2 107
A Primary adrenal non-hodgkin's lymphoma presenting as an incidental adrenal mass 105
Monocyte chemoattractant protein-1 in adipose tissue 104
The desmopressin test may predict the risk of recurrence in Cushing's disease 103
Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism : a multicenter longitudinal study 103
Epicardial fat thickness : relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity 102
Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test 101
Thyroid function and obesity 100
High prevalence of vitamin D deficiency in myotonic dystrophies 100
Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response 99
Acromegaly and thymic hyperplasia : a case report 99
Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity 97
Acute hepatitis after treatment of acromegaly with octreotide 97
Serum and salivary cortisol measurement in obese women : correlation with psycho-physiological profiles 96
Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity : relationship with abdominal fat deposition 96
Adjuvant Mitotane treatment for adrenocortical carcinoma 96
Farmaci interferenti la neuroregolazione 95
Monocyte chemoattractant protein 1 : a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity 92
Adult onset hypoparathyroidism in a patient with psychiatric illness : a 71 years delayed diagnosis of DiGeorge syndrome 92
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency : Italian association study and meta-analysis of European studies 91
Hypercortisolism and arterial hypertension a possible role for vasosuprin 90
Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma 88
Irsutismo 87
Variable clinical presentations in a family with neurohypophysial diabetes insipidus 87
N-terminal pro-brain natriuretic peptide determination as a possible marker of cardiac dysfunction in patients with adrenal disorders 86
Effect of bromocriptine on pituitary tumors 83
Multiple cerebral hemorrhagic foci from metastases during temozolomide treatment in a patient with corticotroph pituitary carcinoma 82
Effectiveness of long-term rosiglitazone administration in patients with Cushing's disease 81
N-terminal pro-B-type natriuretic peptide and echocardiographic abnormalities in severely obese patients: correlation with visceral fat 80
Malattia di Cushing (capitolo 5) 79
Pituitary hyperplasia in severe primary hypothyroidism 75
Relation of visceral adiposity, homocysteine levels and left ventricular morphology 74
Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy : modifications induced by somatostatin (GHRIH) infusion 73
Screening of Cushing's Syndrome in outpatients with type 2 diabetes : results of a prospective multicentric study in Italy 70
Invivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090) 70
L-thyroxine suppressive therapy and autonomic nervous system control in patients with thyroid disease: concerning the article by G. Murialdo et al. 68
Long-term follow-up in adrenal incidentalomas : an Italian multicenter study 65
Totale 9.565
Categoria #
all - tutte 20.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019149 0 0 0 0 0 0 0 0 0 0 80 69
2019/20201.152 117 19 50 96 63 109 171 135 161 145 68 18
2020/20211.210 48 81 125 8 92 66 77 70 194 70 299 80
2021/2022879 71 12 67 29 45 39 99 28 105 94 84 206
2022/20231.253 176 157 127 159 132 226 17 72 122 6 43 16
2023/2024568 17 58 43 40 243 40 32 37 19 34 5 0
Totale 9.565